Much Ado About Nothing

Examining the future of the global pharma industry as two of the world’s biggest superpowers come to blows.

Key Points:

  • According to a new Pew Research Center survey in Q12021, 9 of 10 US adults (89%) considered China a competitor or enemy rather than a partner during the pandemic.
  • Still, in 2020, Chinese FDI in the US stood at the third position in pharma med-devices at $625 million despite the scrutiny tied to FIRRMA (Foreign Investment Risk Review Modernization Act).
  • This perception-based negativity will not impact the market. “Go China and No China” will soon be replaced by “No clarity over China.”

    Get all of our articles and insights as soon as they're published.

    By sharing the information you have entered, you give your express consent to SG Analytics to use the provided information to contact you with relevant information related to its offerings and services as and when required. SG Analytics secures all your personal information from unauthorized access, use or disclosure. For more information, please visit our privacy policy.